DHR Jan 2026 240.000 call
| Previous close | 40.60 |
| Open | 40.60 |
| Bid | 47.60 |
| Ask | 51.10 |
| Strike | 240.00 |
| Expiry date | 2026-01-16 |
| Day's range | 40.60 - 40.60 |
| Contract range | N/A |
| Volume | |
| Open interest | 17 |
PR NewswireDanaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis
Danaher Corporation (NYSE: DHR), a global science and technology innovator ("Danaher"), today launched a collaboration with Johns Hopkins University aiming to develop new methods for diagnosing mild TBI. As part of the Danaher Beacons program, researchers at Johns Hopkins University will leverage technology from Beckman Coulter Diagnostics, a Danaher subsidiary and leader in clinical diagnostics, to potentially establish correlations between a new biomarker panel and clinical outcomes.
ZacksDanaher Corporation (DHR) Is a Trending Stock: Facts to Know Before Betting on It
Danaher (DHR) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
PR NewswireDanaher to Present at Bank of America Securities Healthcare Conference
Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Tuesday, May 14, 2024 at 10:40 a.m. PT. The event will be simultaneously webcast on www.danaher.com.
